ArticleFrontiers in pharmacology2026
Construction and refined management of a pre-prescription review system: a real-world study in a tertiary hospital.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Information technology-driven pre-prescription review system (PPRS) is critical pillars for medication safety. How to balance the efficiency and accuracy of review has become a core issue. This study aims to retrospectively analyze the establishment and application effectiveness of the PPRS for rational drug use. It summarizes the system's limitations and operational challenges encountered, further explores refined management pathways for the system, and provides insights and considerations for smart healthcare to assist clinical practice in promoting rational drug use. Method: A single-center real-world retrospective analysis study was conducted at a tertiary hospital in Chongqing, China. Using evidence-based methods, a descriptive analysis was conducted on the construction and refined management path of PPRS, and its effectiveness was evaluated. Before and after the PPRS went online, prescription and inpatient order data were monitored. Unpaired sample t-test and one-way ANOVA were used to study the primary outcome of the rationality rate of prescriptions and medical orders, and the secondary outcome of the types of unreasonable prescriptions and the changes in system warning levels. Results: The construction and refined management of PPRS have significantly increased the rationality rate between the total prescriptions (92.53% vs Conclusion: The construction and implementation of PPRS is associated with enhancing the rationality of prescriptions and medical orders. Under the guidance of the refined management pathway, a replicable template has been established to support clinical practice in smart healthcare, reduce invalid alerts, and promote personalized medication.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.